Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single
dose, cross over comparative pivotal study. The purpose of this study is to assess the
bioequivalence between Test Product and the corresponding Reference Product under fasting
condition in normal, healthy, adult, human male subjects.